Altimmune (ALT) insider buying

Healthcare · Biotechnology · Market cap $471M

6 open-market purchases of ALT by Altimmune's executives and directors since December 2025, worth $213,778 in total, from SEC Form 4 filings.

The most recent: Gregory L Weaver bought $17,700 on March 6, 2026.

The biggest buyer over the period is Jerome Benedict Durso: 2 purchases, $122,425.

By year

YearPurchasesValue
20263$108,900
20253$104,878

Biggest buyers

InsiderBuysValue
Jerome Benedict Durso
2$122,425
John Gill
1$51,250
Wayne Pisano
1$20,400
Gregory L Weaver
1$17,700
Diane Jorkasky
1$2,003

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 6, 2026 Gregory L Weaver
5,000$3.54$17,700 Form 4
Mar 6, 2026 Jerome Benedict Durso
20,000$3.54$70,800 Form 4
Jan 8, 2026 Wayne Pisano
5,000$4.08$20,400 Form 4
Dec 29, 2025 Diane Jorkasky
527$3.80$2,003 Form 4
Dec 23, 2025 John Gill
12,500$4.10$51,250 Form 4
Dec 22, 2025 Jerome Benedict Durso
12,500$4.13$51,625 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ALT.
Open ALT in Investingly

Questions

Are Altimmune insiders buying the stock?

6 open-market purchases of ALT by Altimmune's executives and directors since December 2025, worth $213,778 in total, from SEC Form 4 filings. The most recent: Gregory L Weaver bought $17,700 on March 6, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Altimmune's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.